It's gone through! Obama signs Sunscreen Innovation Act

By Michelle Yeomans

- Last updated on GMT

It's gone through! Obama signs Sunscreen Innovation Act

Related tags Sunscreen innovation act Sunscreen

President Obama has signed the Sunscreen Innovation Act into law, which modifies the FDA review and approval process of over-the-counter sunscreen ingredients.

Following on from senate approval for the Sunscreen Innovation act in October, the bill has finally been signed by the President which aims to streamline the sunscreen approval regulatory process, enabling the FDA to approve new ingredients far more efficiently.

Until now the system for the approval of OTC sunscreens has been long-winded and bureaucratic, demanding ingredient providers supply a significant amount of paperwork.

The Act will ultimately help to provide Americans with access to the latest sunscreen ingredients, some of which have been widely available for 15 years in Europe, Asia and Latin America. 

That process takes around a year to secure approval but because of the lengthy process a considerable backlog has built up, which means approval is now taking much longer than that.

What does this now mean for sunscreen makers?

The current regulatory system for sunscreens was established in 2002, promulgating a two-part process which classifies such active ingredients under the OTC drug monograph system.

The backlog of ingredients includes eight that have been waiting approval for years - amiloxate, 10%; bemotrizinol, 10%; bisoctrizole, 10%; *diethylhexyl butamido triazone, 3%; drometrizole trisiloxane, 15%; ecamsule, 10%; enzacamene, 4%; *octyl triazone, 5%. 

“If the Sunscreen Innovation Act is passed, we will hopefully see these pending requests either granted or denied within the next year and a half. That, as you can imagine, is beneficial to all as more options for active ingredients will be available for use,”​ regulation law expert Angela Diesch told CosmeticsDesign-Europe.com, back in September.

Founding member of the PASS Coalition, L’Oréal USA had also released a statement prior to passing of the Bill.

“L’Oréal commends the House of Representatives for its unanimous passage of the Senate version of the Sunscreen Innovation Act (S.2141), which will provide American consumers greater access and choice when it comes to the latest and effective sunscreen products available," ​said chief communications officer, Kristina Schake.

Related topics Regulation & Safety Skin Care

Related news

Show more

Related products

show more

Exosomes: Passing Trend or Transformative Reality?

Exosomes: Passing Trend or Transformative Reality?

Content provided by Naolys | 26-Mar-2024 | White Paper

Exosomes, microscopic vesicles naturally present in abundance within Plant Cells, have garnered significant attention within the scientific and cosmetic...

How Nutricosmetics Can Enhance Skin Beauty

How Nutricosmetics Can Enhance Skin Beauty

Content provided by Activ'Inside | 11-Dec-2023 | White Paper

In the ever-evolving realm of nutricosmetics, where inner wellness meets outer beauty, few natural ingredients have captured the spotlight quite like grapes.

Ultimate Antimicrobial Solution for BPC

Ultimate Antimicrobial Solution for BPC

Content provided by Acme-Hardesty Company | 11-Oct-2023 | White Paper

Sharomix™ EG10, a versatile broad-spectrum antimicrobial liquid blend for preserving personal care products, ensures safety at usage levels ranging from...

Acme-Hardesty Expands Product Line into Canada

Acme-Hardesty Expands Product Line into Canada

Content provided by Acme-Hardesty Company | 07-Jul-2023 | Product Brochure

Acme-Hardesty’s latest expansion into Canada includes Resplanta®, Botaneco®, and BYK from our partners Sharon Personal Care and Eckart Effect Pigments...

Related suppliers